Brain [U- 13C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity

Journal of Neuroscience Research

Volumn 89, Issue 12, 2011, Pages 1997-2007

  Nilsen, Linn Hege ^a   Shi, Qingli ^b   Gibson, Gary E ^b   Sonnewald, Ursula ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Glucose; Glutamate; Magnetic resonance spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ASPARTIC ACID; CARBON 13; FUMARIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; N ACETYLASPARTIC ACID; OXOGLUTARATE DEHYDROGENASE; PYRUVATE CARBOXYLASE; PYRUVATE DEHYDROGENASE; SUCCINIC ACID; TAURINE; TYROSINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CEREBELLUM; CITRIC ACID CYCLE; DECARBOXYLATION; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT MOUSE; MASS SPECTROMETRY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM; WILD TYPE;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCOSE; KETOGLUTARATE DEHYDROGENASE COMPLEX; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES;

EID: 80053620508     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22606     Document Type: Article

References (63)

1. Bak LK, Schousboe A, Sonnewald U, Waagepetersen HS. 2006. Glucose is necessary to maintain neurotransmitter homeostasis during synaptic activity in cultured glutamatergic neurons. J Cereb Blood Flow Metab 26: 1285-1297.
2. Bergmeyer HU, Berndt E, Schmidt F, Stork H. 1974. Glucose determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 2nd ed. New York: Academic Press. p 1196-1201.
3. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE. 2005. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57: 695-703.
4. Buerstatte CR, Behar KL, Novotny EJ, Lai JC. 2000. Brain regional development of the activity of alpha-ketoglutarate dehydrogenase complex in the rat. Brain Res Dev Brain Res 125: 139-145.
5. Butterworth RF, Besnard AM. 1990. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab Brain Dis 5: 179-184.
6. Butterworth RF, Giguere JF, Besnard AM. 1985. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex. Neurochem Res 10: 1417-1428.
7. Butterworth RF, Giguere JF, Besnard AM. 1986. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. Alpha-ketoglutarate dehydrogenase. Neurochem Res 11: 567-577.
8. Calingasan NY, Ho DJ, Wille EJ, Campagna MV, Ruan J, Dumont M, Yang L, Shi Q, Gibson GE, Beal MF. 2008. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neuroscience 153: 986-996.
9. Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ, Hsu CC, Faiman MD, Schloss JV, Wu JY. 2001. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J Neurosci Res 66: 612-619.
10. Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW. 1996. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 46: 1715-1720.
11. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P. 2000. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 20: 789-799.
12. B receptors in rat hippocampal CA1 area. Brain Res 864: 298-307.
13. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C. 2001. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77: 408-415.
14. Dumont M, Ho DJ, Calingasan NY, Xu H, Gibson G, Beal MF. 2009. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med 47: 1019-1027.
15. El Idrissi A, Trenkner E. 1999. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19: 9459-9468.
16. Gibson GE, Blass JP. 1976. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites. JNeurochem 26: 1073-1078.
17. Gibson GE, Ksiezak-Reding H, Sheu KF, Mykytyn V, Blass JP. 1984. Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res 9: 803-814.
18. Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P. 1988. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45: 836-840.
19. Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP. 2000a. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48: 297-303.
20. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. 2000b. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 36: 97-112.
21. 13C nuclear magnetic resonance spectroscopy: a novel approach to the study of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 18: 1223-1232.
22. Hakim AM, Pappius HM. 1981. The effect of thiamine deficiency on local cerebral glucose utilization. Ann Neurol 9: 334-339.
23. Hakim AM, Pappius HM. 1983. Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency. Ann Neurol 13: 365-375.
24. 13C NMR spectroscopic study. J Neurochem 64: 2773-2782.
25. Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U. 1997. Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. J Cereb Blood Flow Metab 17: 1230-1238.
26. Howse DC, Duffy TE. 1975. Control of the redox state of the pyridine nucleotides in the rat cerebral cortex. Effect of electroshock-induced seizures. J Neurochem 24: 935-940.
27. Huang HM, Zhang H, Xu H, Gibson GE. 2003. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. Biochim Biophys Acta 1637: 119-126.
28. Huxtable RJ. 1992. Physiological actions of taurine. Physiol Rev 72: 101-163.
29. 1H nuclear magnetic resonance analysis of glutamate in tissue extracts. Anal Biochem 249: 201-206.
30. Karuppagounder SS, Gibson GE. 2008. Thiamine deficiency: a model of metabolic encephalopathy and selective neuronal vulnerability. In: McCandless DW, editor. Metabolic encephalopathy. New York: Springer Press. p 235-260.
31. Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE. 2009. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiol Aging 30: 1587-1600.
32. Klivenyi P, Starkov AA, Calingasan NY, Gardian G, Browne SE, Yang L, Bubber P, Gibson GE, Patel MS, Beal MF. 2004. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 88: 1352-1360.
33. Lai JC, Cooper AJ. 1986. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. JNeurochem 47: 1376-1386.
34. Louzada PR, Lima ACP, Mendonca-Silva DL, Noël F, De Mello FG, Ferreira ST. 2004. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 18: 511-518.
35. Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA. 2003. Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem 86: 824-835.
36. Mastrogiacomo F, Bergeron C, Kish SJ. 1993. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem 61: 2007-2014.
37. 13C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J Cereb Blood Flow Metab 25: 1254-1264.
38. Melø TM, Sonnewald U, Bastholm IA, Nehlig A. 2007. Astrocytes may play a role in the etiology of absence epilepsy: a comparison between immature GAERS not yet expressing seizures and adults. Neurobiol Dis 28: 227-235.
39. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. 1991. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2: 131-134.
40. Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ. 2008. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29: 676-692.
41. 13C nuclear magnetic resonance spectroscopy. J Neurochem 106: 603-612.
42. 14C-trajectography combined with immunohistochemistry. J Cereb Blood Flow Metab 24: 1004-1014.
43. Norenberg MD. 1979. Distribution of glutamine synthetase in the rat central nervous system. J Histochem Cytochem 27: 756-762.
44. Norenberg MD, Martinez-Hernandez A. 1979. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161: 303-310.
45. Novotny EJJr, Ariyan C, Mason GF, O'Reilly J, Haddad GG, Behar KL. 2001. Differential increase in cerebral cortical glucose oxidative metabolism during rat postnatal development is greater in vivo than in vitro. Brain Res 888: 193-202.
46. Oja SS, Saransaari P. 1996. Taurine as osmoregulator and neuromodulator in the brain. Metab Brain Dis 11: 153-164.
47. Park LC, Calingasan NY, Uchida K, Zhang H, Gibson GE. 2000. Metabolic impairment elicits brain cell type-selective changes in oxidative stress and cell death in culture. J Neurochem 74: 114-124.
48. Park LC, Zhang H, Gibson GE. 2001. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech Ageing Dev 123: 21-27.
49. Pomara N, Singh R, Deptula D, Chou JC, Schwartz MB, LeWitt PA. 1992. Glutamate and other CSF amino acids in Alzheimer's disease. Am J Psychiatry 149: 251-254.
50. 13C MR spectroscopy study of lactate as substrate for rat brain. Dev Neurosci 22: 429-436.
51. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334: 752-758.
52. Roberts E, Frankel S. 1950. Gamma-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187: 55-63.
53. Saito K, Barber R, Wu J, Matsuda T, Roberts E, Vaughn JE. 1974. Immunohistochemical localization of glutamate decarboxylase in rat cerebellum. Proc Natl Acad Sci U S A 71: 269-273.
54. 13C]glutamate metabolism in cerebellar granule neurons. J Neurosci Res 83: 450-458.
55. Shank RP, Bennett GS, Freytag SO, Campbell GL. 1985. Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329: 364-367.
56. Shi Q, Risa O, Sonnewald U, Gibson GE. 2009. Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis. J Neurochem 109( Suppl 1): 214-221.
57. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, et al. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273: 942-947.
58. 13C-MRS analysis. Dev Neurosci 18: 434-442.
59. Valenzuela MJ, Sachdev P. 2001. Magnetic resonance spectroscopy in AD. Neurology 56: 592-598.
60. Waagepetersen HS, Qu H, Schousboe A, Sonnewald U. 2001. Elucidation of the quantitative significance of pyruvate carboxylation in cultured cerebellar neurons and astrocytes. J Neurosci Res 66: 763-770.
61. Wu H, Jin Y, Wei J, Jin H, Sha D, Wu JY. 2005. Mode of action of taurine as a neuroprotector. Brain Res 1038: 123-131.
62. Yang L, Shi Q, Ho DJ, Starkov AA, Wille EJ, Xu H, Chen HL, Zhang S, Stack CM, Calingasan NY, Gibson GE, Beal MF. 2009. Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins. Neurobiol Dis 36: 320-330.
63. Zhao N, Zhong C, Wang Y, Zhao Y, Gong N, Zhou G, Xu T, Hong Z. 2008. Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage. Neurobiol Dis 29: 176-185.